Alnylam Pharmaceuticals Stock Sees Short Interest Decline 12.6%
The most recent short interest data has been released by the NASDAQ for the 10/15/2013 settlement date, which shows a 473,780 share decrease in total short interest for Alnylam Pharmaceuticals Inc , to 3,300,814, a decrease of 12.55% since 09/30/2013. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
According to the ETF Finder at ETF Channel, ALNY makes up 2.24% of the SPDR S&P Biotech ETF (XBI) which is lower by about 0.2% on the day Friday. In afternoon trading Friday, ALNY was down about 0.2% on the day.